CLINICAL_TRIALS
trial_result
· 2020-12-17
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder [Phase 2]
Summary
Phase 2 trial evaluating MIN-117 for major depressive disorder has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Minerva Neurosciences | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-12-17